UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9058) 9058
Newsletter (492) 492
Newspaper Article (167) 167
Book Chapter (136) 136
Magazine Article (86) 86
Transcript (26) 26
Dissertation (14) 14
Conference Proceeding (7) 7
Book / eBook (4) 4
Reference (3) 3
Trade Publication Article (3) 3
Web Resource (2) 2
Publication (1) 1
Report (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7096) 7096
science & technology (6585) 6585
life sciences & biomedicine (6171) 6171
male (3568) 3568
protease inhibitors (3323) 3323
hiv infections - drug therapy (3199) 3199
female (3151) 3151
adult (2671) 2671
proteases (2638) 2638
hiv protease inhibitors - adverse effects (2285) 2285
biological and medical sciences (2271) 2271
medical sciences (2143) 2143
middle aged (2135) 2135
infectious diseases (2059) 2059
hiv protease inhibitors - therapeutic use (1718) 1718
hiv (1668) 1668
animals (1649) 1649
drug therapy, combination (1489) 1489
pharmacology & pharmacy (1457) 1457
antiviral agents (1419) 1419
pharmacology. drug treatments (1394) 1394
drug therapy (1335) 1335
aids/hiv (1142) 1142
health aspects (1118) 1118
immunology (1112) 1112
protease inhibitors - therapeutic use (1094) 1094
treatment outcome (1062) 1062
research (1015) 1015
anti-hiv agents - therapeutic use (979) 979
anti-hiv agents - adverse effects (959) 959
hiv protease inhibitors - administration & dosage (910) 910
human immunodeficiency virus--hiv (884) 884
viral diseases (879) 879
risk factors (877) 877
aged (864) 864
hiv infection (811) 811
care and treatment (798) 798
human viral diseases (785) 785
analysis (782) 782
drug interactions (758) 758
antibiotics. antiinfectious agents. antiparasitic agents (745) 745
virology (745) 745
protease inhibitors - adverse effects (739) 739
highly active antiretroviral therapy (737) 737
viral load (731) 731
ritonavir - adverse effects (729) 729
microbiology (726) 726
hiv infections - complications (713) 713
antiretroviral drugs (709) 709
abridged index medicus (706) 706
proteins (700) 700
viral diseases of the lymphoid tissue and the blood. aids (662) 662
ritonavir - therapeutic use (629) 629
reverse transcriptase inhibitors - therapeutic use (615) 615
cd4 lymphocyte count (601) 601
hepatitis c (597) 597
hiv infections - virology (589) 589
protease inhibitors - pharmacology (586) 586
hepatitis c virus (582) 582
aids (578) 578
antiviral agents - therapeutic use (574) 574
ritonavir (535) 535
reverse transcriptase inhibitors - adverse effects (532) 532
antiretroviral therapy (529) 529
adolescent (528) 528
mice (522) 522
ritonavir - administration & dosage (520) 520
hiv-1 (509) 509
medicine & public health (502) 502
physiological aspects (499) 499
clinical trials (479) 479
antiretroviral therapy, highly active - adverse effects (476) 476
protease (473) 473
human immunodeficiency virus (470) 470
medical research (467) 467
hiv-1 - drug effects (466) 466
hepatitis c, chronic - drug therapy (463) 463
protease inhibitor (459) 459
hiv patients (455) 455
medicine (454) 454
hiv protease inhibitors - pharmacokinetics (453) 453
general & internal medicine (450) 450
proteinase inhibitors (448) 448
anti-hiv agents - administration & dosage (445) 445
biochemistry & molecular biology (443) 443
dosage and administration (442) 442
antiretroviral therapy, highly active (441) 441
lopinavir (434) 434
research article (434) 434
medicine, general & internal (424) 424
drug administration schedule (417) 417
prospective studies (406) 406
patients (405) 405
enzymes (404) 404
time factors (403) 403
oncology (401) 401
gastroenterology & hepatology (394) 394
young adult (394) 394
clinical trials as topic (392) 392
dose-response relationship, drug (390) 390
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9613) 9613
Spanish (133) 133
German (112) 112
French (77) 77
Japanese (49) 49
Portuguese (41) 41
Russian (27) 27
Italian (16) 16
Danish (11) 11
Dutch (11) 11
Polish (7) 7
Chinese (5) 5
Swedish (4) 4
Hungarian (3) 3
Hebrew (2) 2
Norwegian (2) 2
Persian (2) 2
Turkish (2) 2
Croatian (1) 1
Czech (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2006, Volume 368, Issue 9548, pp. 1696 - 1705
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Diabetes. Impaired glucose tolerance | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Triazoles - administration & dosage | Triazoles - adverse effects | Glucagon-Like Peptide 1 - administration & dosage | Humans | Pyrazines - administration & dosage | Glucagon-Like Peptide 1 - biosynthesis | Dipeptidyl Peptidase 4 | Glucagon-Like Peptide 1 - physiology | Pyrazines - therapeutic use | Adenosine Deaminase Inhibitors | Peptides - administration & dosage | Hypoglycemic Agents - administration & dosage | Adamantane - therapeutic use | Pyrrolidines | Venoms - administration & dosage | Nitriles | Sitagliptin Phosphate | Adamantane - administration & dosage | Adamantane - adverse effects | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Glucagon-Like Peptide 1 - classification | Hypoglycemic Agents - therapeutic use | Receptors, Glucagon - agonists | Drug Administration Schedule | Glucagon-Like Peptide 1 - analogs & derivatives | Venoms - adverse effects | Glycoproteins - antagonists & inhibitors | Clinical Trials as Topic | Glucagon-Like Peptide-1 Receptor | Dipeptidyl-Peptidase IV Inhibitors | Pyrazines - adverse effects | Venoms - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Hypoglycemic Agents - adverse effects | Liraglutide | Peptides - adverse effects | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Type 2 diabetes | Care and treatment | Diagnosis | Glucagon | Analysis | Dosage and administration | Research | Protease inhibitors | Drug therapy | Proteins | Diabetes | Kinases | Insulin | Rodents | Index Medicus | Abridged Index Medicus
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 03/2012, Volume 55, Issue 3, pp. 742 - 748
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2014, Volume 14, Issue 7, pp. 581 - 589
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Antiviral agents | Immunopathology | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Antibiotics. Antiinfectious agents. Antiparasitic agents | Humans | Middle Aged | Male | Thiazoles - therapeutic use | Thiazoles - adverse effects | Tenofovir | Deoxycytidine - therapeutic use | Drug Therapy, Combination - adverse effects | Adenine - adverse effects | Quinolones - adverse effects | Ritonavir - adverse effects | Adenine - therapeutic use | Quinolones - therapeutic use | Protease Inhibitors - adverse effects | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Protease Inhibitors - therapeutic use | Emtricitabine | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Anti-HIV Agents - adverse effects | Organophosphonates - adverse effects | Drug Therapy, Combination - methods | HIV | Carbamates - adverse effects | HIV Infections - drug therapy | Carbamates - therapeutic use | Viral Load - drug effects | Cobicistat | Deoxycytidine - analogs & derivatives | Adults | Protease inhibitors | Proteases | Antiretroviral drugs | Patient satisfaction | Drug therapy | Laboratories | Human immunodeficiency virus--HIV | Index Medicus
Journal Article
BMC infectious diseases, ISSN 1471-2334, 04/2020, Volume 20, Issue 1, pp. 264 - 264
Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Anilides - therapeutic use | Prospective Studies | Hepatitis C - drug therapy | Anilides - adverse effects | Humans | Middle Aged | Male | Ritonavir - adverse effects | Protease Inhibitors - adverse effects | Ritonavir - therapeutic use | Female | Drug Therapy, Combination | Protease Inhibitors - therapeutic use | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Uracil - therapeutic use | Genotype | Treatment Outcome | Macrocyclic Compounds - adverse effects | Macrocyclic Compounds - therapeutic use | Uracil - adverse effects | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Hepatitis C - virology | Sulfonamides - adverse effects | Carbamates - adverse effects | Carbamates - therapeutic use | Uracil - analogs & derivatives | Medical research | Antiviral agents | Liver diseases | Liver | Biological products industry | Biological response modifiers | Infection | Protease inhibitors | Proteases | Medicine, Experimental | Product development | Drug therapy | Hepatitis C virus | Health aspects | Ritonavir | Health services | Chronic infection | Viruses | Hepatocellular carcinoma | Infections | Ribavirin | Genotype & phenotype | Hepatitis | Protease | Drug dosages | Failure | Genotypes | Medical treatment | Proteinase inhibitors | Patients | Ankle | Side effects | Hypotheses | Fibrosis | Interferon | Hepatitis C | Index Medicus | Direct acting anti-viral agents | HCV | AbbVie 3D | Protease inhibitors failure
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2011, Volume 141, Issue 6, pp. 2047 - 2055
Journal Article
Journal Article